Draft guideline on the clinical development of medicinal products for the treatment of human-immunodeficiency-virus (HIV) infection (revision 3)

  • Email
  • Help

Document details

Download document Draft guideline on the clinical development of medicinal products for the treatment of human-immunodeficiency-virus (HIV) infection (revision 3)
Reference number EMEA/CPMP/EWP/633/02 Rev. 3
Status draft: consultation open
First published 30/09/2013
Last updated 07/10/2013
Consultation start date 30/09/2013
Consultation end date 31/03/2014
Email address for submissions idwpsecretariat@ema.europa.eu

Summary

This guideline provides guidance on the clinical development of direct-acting antiretrovirals for the treatment of human-immunodeficiency-virus (HIV) infection. It replaces EMEA/CPMP/EWP/633/02 Rev 2.